Literature DB >> 8913466

Antitrypanosomal activity of purine nucleosides can be enhanced by their conversion to O-acetylated derivatives.

J R Sufrin1, D Rattendi, A J Spiess, S Lane, C J Marasco, C J Bacchi.   

Abstract

Fifteen purine nucleosides and their O-acetylated ester derivatives were examined for in vitro antitrypanosomal activity against the LAB 110 EATRO isolate of Trypanosoma brucei brucei and two clinical isolates of Trypanosoma brucei rhodesiense. Initial comparisons of activity were made for the LAB 110 EATRO isolate. Three nucleoside analogs exhibited no significant activity (50% inhibitory concentrations [IC50s] of > 100 microM), whether they were O acetylated or unacetylated; three nucleosides showed almost equal activity (IC50s of < 5 microM) for the parent compound and the O-acetylated derivative; nine nucleosides showed significantly improved activity (> or = 3-fold) upon O acetylation; of these nine analogs, six displayed activity at least 10-fold greater than that of their parent nucleosides. The most significant results were those for four apparently inactive compounds which, upon O acetylation, displayed IC50s of < or = 25 microM. When the series of compounds was tested against T. brucei rhodesiense isolates (KETRI 243 and KETRI 269), their antitrypanosomal effects were comparable to those observed for the EATRO 110 strain. Thus, our studies of purine nucleosides have determined that O acetylation consistently improved their in vitro antitrypanosomal activity. This observed phenomenon was independent of their cellular enzyme targets (i.e., S-adenosylmethionine, polyamine, or purine salvage pathways). On the basis of our results, the routine preparation of O-acetylated purine nucleosides for in vitro screening of antitrypanosomal activity is recommended, since O acetylation transformed several inactive nucleosides into compounds with significant activity, presumably by improving uptake characteristics. O-acetylated purine nucleosides may offer in vivo therapeutic advantages compared with their parent nucleosides, and this possibility should be considered in future evaluations of this structural class of trypanocides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913466      PMCID: PMC163577     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Uptake of the antitrypanosomal drug 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine (MDL 73811) by the purine transport system of Trypanosoma brucei brucei.

Authors:  T L Byers; P Casara; A J Bitonti
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

2.  Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers.

Authors:  H Hirumi; K Hirumi
Journal:  J Parasitol       Date:  1989-12       Impact factor: 1.276

3.  Analogs of 6-methyl-9-beta-D-ribofuranosylpurine.

Authors:  J A Montgomery; K Hewson
Journal:  J Med Chem       Date:  1968-01       Impact factor: 7.446

4.  Inactivation of S-adenosylhomocysteine hydrolase by 5'-deoxy-5'-methylthioadenosine.

Authors:  A J Ferro; A A Vandenbark; M R MacDonald
Journal:  Biochem Biophys Res Commun       Date:  1981-05-29       Impact factor: 3.575

5.  Methylthioadenosine, a potent inhibitor of spermine synthase from bovine brain.

Authors:  R L Pajula; A Raina
Journal:  FEBS Lett       Date:  1979-03-15       Impact factor: 4.124

6.  5'-Alkyl-substituted analogs of 5'-methylthioadenosine as trypanocides.

Authors:  C J Bacchi; J R Sufrin; H C Nathan; A J Spiess; T Hannan; J Garofalo; K Alecia; L Katz; N Yarlett
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

7.  Targeting 5'-deoxy-5'-(methylthio)adenosine phosphorylase by 5'-haloalkyl analogues of 5'-deoxy-5'-(methylthio)adenosine.

Authors:  J R Sufrin; A J Spiess; D L Kramer; P R Libby; J T Miller; R J Bernacki; Y H Lee; R T Borchardt; C W Porter
Journal:  J Med Chem       Date:  1991-08       Impact factor: 7.446

8.  Studies of inhibition of rat spermidine synthase and spermine synthase.

Authors:  H Hibasami; R T Borchardt; S Y Chen; J K Coward; A E Pegg
Journal:  Biochem J       Date:  1980-05-01       Impact factor: 3.857

9.  Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase.

Authors:  A J Bitonti; T L Byers; T L Bush; P J Casara; C J Bacchi; A B Clarkson; P P McCann; A Sjoerdsma
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

10.  Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei.

Authors:  N S Carter; B J Berger; A H Fairlamb
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

View more
  5 in total

1.  Novel trypanocidal analogs of 5'-(methylthio)-adenosine.

Authors:  Janice R Sufrin; Arthur J Spiess; Canio J Marasco; Donna Rattendi; Cyrus J Bacchi
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

2.  In vivo efficacies of 5'-methylthioadenosine analogs as trypanocides.

Authors:  C J Bacchi; K Sanabria; A J Spiess; M Vargas; C J Marasco; L M Jimenez; B Goldberg; J R Sufrin
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

3.  Trypanocidal activity of 8-methyl-5'-{[(Z)-4-aminobut-2-enyl]-(methylamino)}adenosine (Genz-644131), an adenosylmethionine decarboxylase inhibitor.

Authors:  Cyrus J Bacchi; Robert H Barker; Aixa Rodriguez; Bradford Hirth; Donna Rattendi; Nigel Yarlett; Clifford L Hendrick; Edmund Sybertz
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

4.  Design and synthesis of a series of truncated neplanocin fleximers.

Authors:  Sarah C Zimmermann; Elizaveta O'Neill; Godwin U Ebiloma; Lynsey J M Wallace; Harry P De Koning; Katherine L Seley-Radtke
Journal:  Molecules       Date:  2014-12-16       Impact factor: 4.411

5.  Improved synthesis of beta-D-6-methylpurine riboside and antitumor effects of the beta-D- and alpha-D-anomers.

Authors:  Canio J Marasco; Paula J Pera; Arthur J Spiess; Ralph Bernacki; Janice R Sufrin
Journal:  Molecules       Date:  2005-08-31       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.